TradeUP Acquisition Corp. (UPTD) Signs Additional Subscription Agreements Ahead of Close
by Kristi Marvin on 2023-09-20 at 4:39pm

TradeUP (NASDAQ:UPTD) announced in an 8-K this afternoon that has entered into additional subscription agreements in connection with its combination with Estrella Biopharma.

Under these subscription agreements, Plentiful Limited and Lianhe World Limited, collectively known as the “Investors”, agreed to each buy $5,000,000 worth of UPTD’s common stock, priced at $10.00 per share.  However, if, at the Closing, the volume weighted average price of the shares over the fifteen trading days leading up to it (referred to as the “VWAP”) falls below $8.30, each Investor has the right to receive extra shares. This extra share count is calculated as the difference between $8.30 and the VWAP at the Closing, multiplied by 100,000.

Within thirty days after the Closing, each Investor is also entitled to receive an additional 704,819 shares. Furthermore, if, on the date 24 months after the Closing (the “24-Month Date”), the VWAP of the shares for the fifteen trading days leading up to that date (the “24-Month Date VWAP”) falls below $8.30, each Investor has the right to receive more shares. The number of extra shares is determined by the difference between $8.30 and the 24-Month Date VWAP, multiplied by the difference between the number of shares held by the Investor on the 24-Month Date and the number of shares acquired by the Investor after the Closing, divided by $10.00.

TradeUp initially announced its $398 million combination with Estrella Biopharma in October 2022. The combination was approved by shareholders on July 31, 2023, but the deal is still working its way to a close. However, today’s 8-k states that the combined company’s anticipated first date of trading will be in October 2023.

Emeryville, California-based Estrella is developing three potential cancer therapies aimed at improving the effectiveness of T-cell treatments.

Recent Posts
by Nicholas Alan Clayton on 2024-06-17 at 7:50pm

Melar Acquisition Corp. I announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “MACIU”, Tuesday, June 18, 2024. The new SPAC aims to combine with a company in retail finance, specialty finance or financial technology specifically targeted at helping small businesses transact...

by Nicholas Alan Clayton on 2024-06-17 at 7:48pm

Lionheart Holdings announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “CUBBU”, Tuesday, June 18, 2024. The new SPAC aims to combine with an established business of scale with a highly regarded management team, but has not singled out a specific industry...

by Nicholas Alan Clayton on 2024-06-17 at 2:03pm

After bringing several serial SPAC sponsors back to market, underwriter Cantor Fitzgerald is getting its own team back in the game by filing for CF A‘s (NASDAQ:CFFA) $100 million SPAC IPO, and it seems to have saved its boldest SPAC terms for itself. CF A returns Cantor Fitzgerald Chairman and CEO Howard Lutnick to the...

by Nicholas Alan Clayton on 2024-06-17 at 8:13am

At the SPAC of Dawn SPAC action may slow slightly this week as the US trading is to be split in two by the Wednesday Juneteenth holiday. On the voting end, Feutune Light (NASDAQ:FLFV) is slated to be the only SPAC voting to approve a transaction while three more are to hold extension votes. Among...

by Kristi Marvin on 2024-06-15 at 11:30am

Terms Tracker for the Week Ending June 14, 2024 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. It was all about the new IPOs and new SPACs getting filed again this week. Cantor managed to price one new IPO on Monday night...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved